Magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) was used to quantify fat.


 Mean pancreas MRI-PDFF was significantly higher in diabetics (13.7% ± 3.6% vs. 8.7% ± 5.1%, p = 0.001).  There was no significant pancreas MRI-PDFF difference between NASH and non-NASH (P = 0.95).  Mean pancreas MRI-PDFF was significantly higher in patients with PEI (13.7% ± 3.4% vs. 8.9% ± 5.2%, P < 0.01).



MRI-PDFF
Magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) was used to quantify fat.


 Mean pancreas MRI-PDFF was significantly higher in diabetics (13.7% ± 3.6% vs. 8.7% ± 5.1%, p = 0.001).  There was no significant pancreas MRI-PDFF difference between NASH and non-NASH (P = 0.95).  Mean pancreas MRI-PDFF was significantly higher in patients with PEI (13.7% ± 3.4% vs. 8.9% ± 5.2%, P < 0.01).



MRI-PDFF
Magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) was used to quantify fat.


 Mean pancreas MRI-PDFF was significantly higher in diabetics (13.7% ± 3.6% vs. 8.7% ± 5.1%, p = 0.001).  There was no significant pancreas MRI-PDFF difference between NASH and non-NASH (P = 0.95).  Mean pancreas MRI-PDFF was significantly higher in patients with PEI (13.7% ± 3.4% vs. 8.9% ± 5.2%, P < 0.01).



MRI-PDFF
Magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) was used to quantify fat.


 Mean pancreas MRI-PDFF was significantly higher in diabetics (13.7% ± 3.6% vs. 8.7% ± 5.1%, p = 0.001).  There was no significant pancreas MRI-PDFF difference between NASH and non-NASH (P = 0.95).  Mean pancreas MRI-PDFF was significantly higher in patients with PEI (13.7% ± 3.4% vs. 8.9% ± 5.2%, P < 0.01).



MRI-PDFF
Magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) was used to quantify fat.


 Mean pancreas MRI-PDFF was significantly higher in diabetics (13.7% ± 3.6% vs. 8.7% ± 5.1%, p = 0.001).  There was no significant pancreas MRI-PDFF difference between NASH and non-NASH (P = 0.95).  Mean pancreas MRI-PDFF was significantly higher in patients with PEI (13.7% ± 3.4% vs. 8.9% ± 5.2%, P < 0.01).



MRI-PDFF
Magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) was used to quantify fat.


 Mean pancreas MRI-PDFF was significantly higher in diabetics (13.7% ± 3.6% vs. 8.7% ± 5.1%, p = 0.001).  There was no significant pancreas MRI-PDFF difference between NASH and non-NASH (P = 0.95).  Mean pancreas MRI-PDFF was significantly higher in patients with PEI (13.7% ± 3.4% vs. 8.9% ± 5.2%, P < 0.01).



MRI-PDFF